Thermo Fisher Scientific Inc.
TMO | NYSE
$686.04
-$10.96 (-1.57%)
Nov 2, 2026, 12:40 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 9.85B | 4.02B | 8.08B | 8.52B | 4.48B | 10.33B |
Short-Term Investments | 253M | 1.56B | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 560M | 59M | 155M | 73M | 65M |
Other Long-Term Assets | 5.87B | 2.44B | 2.38B | 2.22B | 3B | 1.57B |
Receivables | 10.57B | 9.63B | 9.66B | 9.43B | 8.95B | 6.47B |
Inventory | 5.43B | 4.98B | 5.09B | 5.63B | 5.05B | 4.03B |
Other Current Assets | 2.61B | 1.95B | 1.76B | 1.64B | 1.64B | 1.13B |
Total Current Assets | 28.71B | 22.14B | 24.59B | 25.23B | 20.11B | 21.96B |
Property-Plant & Equipment | 10.57B | 10.8B | 11B | 10.87B | 9.86B | 6.69B |
Goodwill & Intangibles | 65.2B | 61.39B | 60.69B | 58.67B | 62.07B | 38.77B |
Total Long-Term Assets | 81.64B | 75.18B | 74.14B | 71.93B | 75.01B | 47.1B |
Total Assets | 110.34B | 97.32B | 98.73B | 97.15B | 95.12B | 69.05B |
Account Payables | 3.62B | 3.08B | 2.87B | 3.38B | 2.87B | 2.18B |
Deferred Revenue | 2.71B | 2.85B | 2.69B | 2.6B | 2.66B | 1.27B |
Short-Term Debt | 3.53B | 2.48B | 3.87B | 5.85B | 2.8B | 2.81B |
Other Current Liabilities | n/a | 2.94B | 2.98B | 3.08B | 2.68B | 2.13B |
Total Current Liabilities | 15.19B | 13.33B | 14.01B | 17.01B | 13.44B | 10.3B |
Long-Term Debt | 35.85B | 29.06B | 31.31B | 28.91B | 32.15B | 19.11B |
Other Long-Term Liabilities | 4.27B | 1.61B | 1.9B | 1.75B | 2.1B | 1.94B |
Total Long-Term Liabilities | 41.62B | 34.32B | 37.87B | 36B | 40.71B | 24.23B |
Total Liabilities | 56.81B | 47.65B | 51.88B | 53.01B | 54.15B | 34.54B |
Total Debt | 39.39B | 32.78B | 36.42B | 36.07B | 36.34B | 22.55B |
Book Value | 53.54B | 49.67B | 46.84B | 44.15B | 40.98B | 34.52B |
Book Value Per Share | 142.01 | 129.69 | 120.73 | 112.05 | 103.22 | 86.51 |
Common Stock | 445M | 444M | 442M | 441M | 439M | 437M |
Retained Earnings | 59.16B | 53.1B | 47.36B | 41.91B | 35.43B | 28.12B |
Comprehensive Income | -2.45B | -2.7B | -3.22B | -3.1B | -2.33B | -2.81B |
Shareholders Equity | 53.41B | 49.58B | 46.74B | 43.98B | 40.79B | 34.51B |
Total Investments | 253M | 2.12B | 59M | 155M | 73M | 65M |
Add to Watchlist
Select watchlists to add or remove TMO